These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20118207)

  • 21. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-melanocyte stimulating hormone modulates the central acyl ghrelin-induced stimulation of feeding, gastrointestinal motility, and colonic secretion.
    Huang HH; Chen LY; Doong ML; Chang SC; Chen CY
    Drug Des Devel Ther; 2017; 11():2377-2386. PubMed ID: 28860709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
    Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
    J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP.
    Zheng H; Corkern MM; Crousillac SM; Patterson LM; Phifer CB; Berthoud HR
    Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1773-81. PubMed ID: 12010760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of the Hypothalamic Melanocortin System Decreases in Middle-Aged and Increases in Old Rats.
    Füredi N; Mikó A; Gaszner B; Feller D; Rostás I; Tenk J; Solymár M; Balaskó M; Pétervári E
    J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(4):438-445. PubMed ID: 29099963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.
    Beckman TR; Shi Q; Levine AS; Billington CJ
    Physiol Behav; 2009 Mar; 96(4-5):568-73. PubMed ID: 19136019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats.
    Flores-Bastías O; Gómez GI; Orellana JA; Karahanian E
    Curr Pharm Des; 2019; 25(45):4799-4805. PubMed ID: 31840601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression in hypothalamus, liver, and adipose tissues and food intake response to melanocortin-4 receptor agonist in pigs expressing melanocortin-4 receptor mutations.
    Barb CR; Hausman GJ; Rekaya R; Lents CA; Lkhagvadorj S; Qu L; Cai W; Couture OP; Anderson LL; Dekkers JC; Tuggle CK
    Physiol Genomics; 2010 May; 41(3):254-68. PubMed ID: 20215418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning, pharmacological characterization, and brain mapping of the melanocortin 4 receptor in the goldfish: involvement in the control of food intake.
    Cerdá-Reverter JM; Ringholm A; Schiöth HB; Peter RE
    Endocrinology; 2003 Jun; 144(6):2336-49. PubMed ID: 12746294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system.
    Satoh N; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Yoshimasa Y; Nakao K
    Neurosci Lett; 1998 Jun; 249(2-3):107-10. PubMed ID: 9682828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
    Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
    Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice.
    Weyermann P; Dallmann R; Magyar J; Anklin C; Hufschmid M; Dubach-Powell J; Courdier-Fruh I; Henneböhle M; Nordhoff S; Mondadori C
    PLoS One; 2009; 4(3):e4774. PubMed ID: 19295909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
    Hoggard N; Rayner DV; Johnston SL; Speakman JR
    J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial uncoupling in the melanocortin system differentially regulates NPY and POMC neurons to promote weight-loss.
    Michael NJ; Simonds SE; van den Top M; Cowley MA; Spanswick D
    Mol Metab; 2017 Oct; 6(10):1103-1112. PubMed ID: 29031712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet.
    Hansen MJ; Schiöth HB; Morris MJ
    Brain Res; 2005 Mar; 1039(1-2):137-45. PubMed ID: 15781055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.
    Gardiner JV; Bataveljic A; Patel NA; Bewick GA; Roy D; Campbell D; Greenwood HC; Murphy KG; Hameed S; Jethwa PH; Ebling FJ; Vickers SP; Cheetham S; Ghatei MA; Bloom SR; Dhillo WS
    Diabetes; 2010 Feb; 59(2):397-406. PubMed ID: 19933997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist.
    Kim RY; Shin SW; Kim BJ; Lee W; Baik JH
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1178-85. PubMed ID: 15766551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
    Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
    J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia.
    do Carmo JM; da Silva AA; Moak SP; da Silva FS; Spradley FT; Hall JE
    Acta Physiol (Oxf); 2019 Apr; 225(4):e13222. PubMed ID: 30466186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.